Exhibit 10.10 Confidential portions of this Agreement have been omitted pursuant to an order granting confidential treatment issued by the Commission on May 11, 2005, pursuant to Rule 406 of the Securities Act of 1933, as amended. [GRAPHIC OMITTED]...Phase Ii Agreement • May 13th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances)
From: Edward CofflandPhase Ii Agreement • July 12th, 2024
